Establishment and characterization of a hUCMSC model of Mycobacterium smegmatis infection
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference [42]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    [Background] The formation of dormant Mycobacterium tuberculosis (Mtb) is considered to be the main cause of latent tuberculosis infection (LTBI), the mechanism of which remains to be studied with in vivo and in vitro models. Mtb can infect mesenchymal stem cells (MSC) and survive in the cells in a dormant state for a long time. However, the modeling of Mtb-infected cells requires long time and high laboratory biosafety level. Therefore, it is essential to explore the available MSC for modeling Mtb infection and further deciphering the dormancy mechanism of Mtb. [Objective] To establish and characterize the human umbilical cord MSC (hUCMSC) model of Mycobacterium smegmatis (Ms) infection. [Methods] After hUCMSC were infected with Ms, flow cytometry was employed to identify the surface antigen. The cell membrane was labeled with DiI and then the phagocytosis of the hUCMSC infected with Ms was observed in a fluorescence microscope. The plate counting method was employed to measure the intracellular survival rate of Ms. The formation of lipid droplets in hUCMSC was observed by oil red O staining. Cytoskeletal changes were observed by fluorescence staining with phalloidin. The transcription levels of the genes involved in the lipid metabolism, resting, and differentiation of the hUCMSC infected with Ms were determined by RT-qPCR. [Results] Ms survived in hUCMSC in a non-replicating state, and the infection rate was positively correlated with the multiplicity of infection. Ms simulated the expression of the genes involved in lipid biosynthesis and inhibited the transcription of the genes involved in lipid degradation to promote the formation of lipid droplets in the Ms-infected hUCMSC. Ms promoted the cytoskeleton remodeling of hUCMSC. The RT-qPCR results showed up-regulated expression of the genes related to proliferation and differentiation, indicating that Ms promoted the differentiation of hUCMSC into lipoblasts and osteoblasts. [Conclusion] We successfully established a hUCMSC model of Ms infection, which could mimic the main characteristics of Mtb dormancy and be used in the study of LTBI mechanism.

    Reference
    [1] CHAKAYA J, PETERSEN E, NANTANDA R, MUNGAI BN, MIGLIORI GB, AMANULLAH F, LUNGU P, NTOUMI F, KUMARASAMY N, MAEURER M, ZUMLA A. The WHO global tuberculosis 2021 report-not so good news and turning the tide back to End TB[J]. International Journal of Infectious Diseases:IJID:Official Publication of the International Society for Infectious Diseases, 2022, 124(Suppl 1):S26-S29.
    [2] ALSAYED SSR, GUNOSEWOYO H. Tuberculosis:pathogenesis, current treatment regimens and new drug targets[J]. International Journal of Molecular Sciences, 2023, 24(6):5202.
    [3] CHEE CBE, REVES R, ZHANG Y, BELKNAP R. Latent tuberculosis infection:opportunities and challenges[J]. Respirology, 2018, 23(10):893-900.
    [4] FATIMA S, KAMBLE SS, DWIVEDI VP, BHATTACHARYA D, KUMAR S, RANGANATHAN A, van KAER L, MOHANTY S, DAS G. Mycobacterium tuberculosis programs mesenchymal stem cells to establish dormancy and persistence[J]. The Journal of Clinical Investigation, 2020, 130(2):655-661.
    [5] BEAMER G, MAJOR S, DAS B, CAMPOS-NETO A. Bone marrow mesenchymal stem cells provide an antibiotic-protective niche for persistent viable Mycobacterium tuberculosis that survive antibiotic treatment[J]. The American Journal of Pathology, 2014, 184(12):3170-3175.
    [6] YANG H, SHA W, LIU ZH, TANG TQ, LIU HP, QIN LH, CUI ZL, CHEN JX, LIU F, ZHENG RJ, HUANG XC, WANG J, FENG YH, GE BX. Lysine acetylation of DosR regulates the hypoxia response of Mycobacterium tuberculosis[J]. Emerging Microbes & Infections, 2018, 7(1):34.
    [7] SHI SD, HSUEH PR, YANG PC, CHOU CC. Use of DosR dormancy antigens from Mycobacterium tuberculosis for serodiagnosis of active and latent tuberculosis[J]. ACS Infectious Diseases, 2020, 6(2):272-280.
    [8] JIANG H, LUO tTL, KANG J, XU ZK, WANG LM. Expression of Rv2031c-Rv2626c fusion protein in Mycobacterium smegmatis enhances bacillary survival and modulates innate immunity in macrophages[J]. Molecular Medicine Reports, 2018, 17(5):7307-7312.
    [9] SALINA EG, GRIGOROV AS, BYCHENKO OS, SKVORTSOVA YV, MAMEDOV IZ, AZHIKINA TL, KAPRELYANTS AS. Resuscitation of dormant "non-culturable" Mycobacterium tuberculosis is characterized by immediate transcriptional burst[J]. Frontiers in Cellular and Infection Microbiology, 2019, 9:272.
    [10] DAS B, KASHINO SS, PULU I, KALITA D, SWAMI V, YEGER H, FELSHER DW, CAMPOS-NETO A. CD271(+) bone marrow mesenchymal stem cells may provide a niche for dormant Mycobacterium tuberculosis[J]. Science Translational Medicine, 2013, 5(170):170ra13.
    [11] GARHYAN J, BHUYAN S, PULU I, KALITA D, DAS B, BHATNAGAR R. Preclinical and clinical evidence of Mycobacterium tuberculosis persistence in the hypoxic niche of bone marrow mesenchymal stem cells after therapy[J]. The American Journal of Pathology, 2015, 185(7):1924-1934.
    [12] TORNACK J, REECE ST, BAUER WM, VOGELZANG A, BANDERMANN S, ZEDLER U, STINGL G, KAUFMANN SHE, MELCHERS F. Human and mouse hematopoietic stem cells are a depot for dormant Mycobacterium tuberculosis[J]. PLoS One, 2017, 12(1):e0169119.
    [13] SINGH VK, MISHRA A, BARK S, MANI A, SUBBIAN S, HUNTER RL, JAGANNATH C, KHAN A. Human mesenchymal stem cell based intracellular dormancy model of Mycobacterium tuberculosis[J]. Microbes and Infection, 2020, 22(9):423-431.
    [14] SAKALLIOGLU IT, MAROLI AS, de LIMA LEITE A, MARSHALL DD, EVANS BW, ZINNIEL DK, DUSSAULT PH, BARLETTA RG, POWERS R. Multi-omics investigation into the mechanism of action of an anti-tubercular fatty acid analogue[J]. Journal of the American Chemical Society, 2022, 144(46):21157-21173.
    [15] KIM JS, KIM HK, CHO E, MUN SJ, JANG S, JANG J, YANG CS. PE_PGRS38 interaction with HAUSP downregulates antimycobacterial host defense via TRAF6[J]. Frontiers in Immunology, 2022, 13:862628.
    [16] TANG YT, MU A, ZHANG YY, ZHOU S, WANG WW, LAI YZ, ZHOU XT, LIU FJ, YANG XN, GONG HR, WANG Q, RAO ZH. Cryo-EM structure of Mycobacterium smegmatis DyP-loaded encapsulin[J]. Proceedings of the National Academy of Sciences of the United States of America, 2021, 118(16):e2025658118.
    [17] 侯晓青, 刘丹, 王易. 耻垢分枝杆菌在感染与免疫研究中的应用[J]. 微生物与感染, 2014, 9(4):238-244. HOU XQ, LIU D, WANG Y. Mycobacterium smegmatis:a mosel bacterium for tuberculosis and its current roles in research of infection and immunity[J]. Journal of microbes and infections, 2014, 9(4):238-244(in Chinese).
    [18] MAMADOU D, MARIE-ANGE D, NICOLE G. The cell envelope of Mycobacterium smegmatis:cytochemistry and architectural implications[J]. FEMS Microbiology Letters, 1989, 61(1-2):89-93.
    [19] JOSEPH SUNDARSINGH T, RANJITHA J, RAJAN A, SHANKAR V. Features of the biochemistry of Mycobacterium smegmatis, as a possible model for Mycobacterium tuberculosis[J]. Journal of Infection and Public Health, 2020, 13(9):1255-1264.
    [20] GRIGOROV A, BYCHENKO O, SALINA EG, SKVORTSOVA Y, MAZUROVA A, SKVORTSOV T, KAPRELYANTS A, AZHIKINA T. Small RNA F6 provides Mycobacterium smegmatis entry into dormancy[J]. International Journal of Molecular Sciences, 2021, 22(21):11536.
    [21] DOMINICI M, Le BLANC K, MUELLER I, SLAPER-CORTENBACH I, MARINI F, KRAUSE D, DEANS R, KEATING A, PROCKOP D, HORWITZ E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement[J]. Cytotherapy, 2006, 8(4):315-317.
    [22] PENG X, ZHANG Y, BAI GC, ZHOU XD, WU H. Cyclic di-AMP mediates biofilm formation[J]. Molecular Microbiology, 2016, 99(5):945-959.
    [23] SINGH V, KAUR C, CHAUDHARY VK, RAO KVS, CHATTERJEE SM. Tuberculosis secretory protein ESAT-6 induces metabolic flux perturbations to drive foamy macrophage differentiation[J]. Scientific Reports, 2015, 5:12906.
    [24] VATER C, KASTEN P, STIEHLER M. Culture media for the differentiation of mesenchymal stromal cells[J]. Acta Biomaterialia, 2011, 7(2):463-477.
    [25] JAGGER A, REITER-KARAM S, HAMADA Y, GETAHUN H. National policies on the management of latent tuberculosis infection:review of 98 countries[J]. Bulletin of the World Health Organization, 2018, 96(3):173-184F.
    [26] GETAHUN H, MATTEELLI A, ABUBAKAR I, ABDEL AZIZ M, BADDELEY A, BARREIRA D, den BOON S, GUTIERREZ SMB, BRUCHFELD J, BURHAN E, CAVALCANTE S, CEDILLOS R, CHAISSON R, CHEE CBE, CHESIRE L, CORBETT E, DARA M, DENHOLM J, de VRIES G, FALZON D, et al. Management of latent Mycobacterium tuberculosis infection:who guidelines for low tuberculosis burden countries[J]. The European Respiratory Journal, 2015, 46(6):1563-1576.
    [27] BATYRSHINA YR, SCHWARTZ YS. Modeling of Mycobacterium tuberculosis dormancy in bacterial cultures[J]. Tuberculosis, 2019, 117:7-17.
    [28] LIU YJ, PERTINEZ H, DAVIES GR, GILLESPIE SH, COATES AR, HU YM. Moxifloxacin replacement in contemporary tuberculosis drug regimens is ineffective against persistent Mycobacterium tuberculosis in the Cornell mouse model[J]. Antimicrobial Agents and Chemotherapy, 2018, 62(7):e00190-18.
    [29] TIZZANO B, DALLENGA TK, UTPATEL C, BEHRENDS J, HOMOLKA S, KOHL TA, NIEMANN S. Survival of hypoxia-induced dormancy is not a common feature of all strains of the Mycobacterium tuberculosis complex[J]. Scientific Reports, 2021, 11(1):2628.
    [30] CHANG DPS, GUAN XL. Metabolic versatility of Mycobacterium tuberculosis during infection and dormancy[J]. Metabolites, 2021, 11(2):88.
    [31] GARCIA-MORALES L, LEON-SOLIS L, MONROY-MUÑOZ IE, TALAVERA-PAULIN M, SERAFIN-LÓPEZ J, ESTRADA-GARCIA I, RIVERA-GUTIERREZ S, CERNA-CORTES JF, HELGUERA-REPETTO AC, GONZALEZ-Y-MERCHAND JA. Comparative proteomic profiles reveal characteristic Mycobacterium tuberculosis proteins induced by cholesterol during dormancy conditions[J]. Microbiology, 2017, 163(8):1237-1247.
    [32] SALINA EG, WADDELL SJ, HOFFMANN N, ROSENKRANDS I, BUTCHER PD, KAPRELYANTS AS. Potassium availability triggers Mycobacterium tuberculosis transition to, and resuscitation from, non-culturable (dormant) states[J]. Open Biology, 2014, 4(10):140106.
    [33] RAGHUNANDANAN S, JOSE L, KUMAR RA. Dormant Mycobacterium tuberculosis converts isoniazid to the active drug in a Wayne's model of dormancy[J]. The Journal of Antibiotics, 2018, 71(11):939-949.
    [34] PETERSON EJR, ABIDI AA, ARRIETA-ORTIZ ML, AGUILAR B, YURKOVICH JT, KAUR A, PAN M, SRINIVAS V, SHMULEVICH I, BALIGA NS. Intricate genetic programs controlling dormancy in Mycobacterium tuberculosis[J]. Cell Reports, 2020, 31(4):107577.
    [35] KHAN A, MANN L, PAPANNA R, LYU MA, SINGH CR, OLSON S, EISSA NT, CIRILLO J, DAS G, HUNTER RL, JAGANNATH C. Mesenchymal stem cells internalize Mycobacterium tuberculosis through scavenger receptors and restrict bacterial growth through autophagy[J]. Scientific Reports, 2017, 7(1):15010.
    [36] NING HH, ZHANG W, KANG J, DING TB, LIANG X, LU YZ, GUO CX, SUN WJ, WANG HP, BAI YL, SHEN LX. Subunit vaccine ESAT-6:c-di-AMP delivered by intranasal route elicits immune responses and protects against Mycobacterium tuberculosis infection[J]. Frontiers in Cellular and Infection Microbiology, 2021, 11:647220.
    [37] PEDDIREDDY V, DODDAM SN, AHMED N. Mycobacterial dormancy systems and host responses in tuberculosis[J]. Frontiers in Immunology, 2017, 8:84.
    [38] ZANOTELLI MR, ZHANG J, REINHART-KING CA. Mechanoresponsive metabolism in cancer cell migration and metastasis[J]. Cell Metabolism, 2021, 33(7):1307-1321.
    [39] SENGUPTA S, PARENT CA, BEAR JE. The principles of directed cell migration[J]. Nature Reviews Molecular Cell Biology, 2021, 22(8):529-547.
    [40] SAIDOVA AA, VOROBJEV IA. Lineage commitment, signaling pathways, and the cytoskeleton systems in mesenchymal stem cells[J]. Tissue Engineering Part B, Reviews, 2020, 26(1):13-25.
    [41] 王荣. 不同供者来源脐带间充质干细胞生物学特性差异的初步研究[D]. 北京:北京协和医学院中国医学科学院清华大学医学部硕士学位论文, 2014. WANG R. Preliminary study on biologic characteristics of umbilical cord mesenchymal stem cells from different donors[D]. Beijing:Master's Thesis of Beijing Union Medical College Chinese Academy of Medical Sciences Tsinghua University Department of Medicine, 2014(in Chinese).
    [42] RAILEANU VN, WHITELEY J, CHOW T, KOLLARA A, MOHAMED A, KEATING A, ROGERS IM. Banking mesenchymal stromal cells from umbilical cord tissue:large sample size analysis reveals consistency between donors[J]. Stem Cells Translations Medicine, 2019, 8(10):1041-1054.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

KANG Yali, NING Huanhuan, XIE Yanling, REN Rui, BAI Lu, LU Yanzhi, KANG Jian, WEI Yin, ZHANG Linna, BAI Yinlan. Establishment and characterization of a hUCMSC model of Mycobacterium smegmatis infection[J]. Microbiology China, 2023, 50(11): 5031-5044

Copy
Share
Article Metrics
  • Abstract:267
  • PDF: 687
  • HTML: 576
  • Cited by: 0
History
  • Received:April 11,2023
  • Adopted:July 11,2023
  • Online: November 06,2023
  • Published: November 20,2023
Article QR Code